Targeting protease activated receptor 1 to promote myelin repair

Project: Research project

Project Details


Researchers at the Mayo Clinic are investigating the importance of a molecule called PAR1 in myelin protection and repair to determine if currently approved drugs that target PAR1 for treatment of other diseases could be used to treat people with MS.

Effective start/end date4/1/153/31/18


  • National Multiple Sclerosis Society: $607,111.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.